Consumers are changing how they use healthcare, Cheek says, and they are adopting digital solutions and home solutions at rapid rates we havent seen before. The Series D round includes investments from a host of experienced investors including BlackRock, The Chernin Group, Foresite Capital, Greenspring Associates, Lux Capital, Morningside Ventures, Portfolia, Goodwater Capital, Highland Capital Partners and Next Coast Ventures
Evidence & regulatory status Evidence base: a large Phase 3 programme (SUSTAIN in type 2 diabetes, STEP in weight management, SELECT in cardiovascular outcomes) plus extensive pharmacokinetic characterization
Many people take semaglutide until: They reach a healthy, sustainable weight Hunger feels manageable without medication support Weight has remained stable for several months The goal isnt just losing weight, its keeping it off in a way that feels realistic
Im sticking with it
Unlike liposomal types, it offers superior stability and proven efficacy
[26] Jastreboff, A